LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
LifeMD (NASDAQ: LFMD) has launched its state-of-the-art affiliated pharmacy in Lancaster, PA, completing its end-to-end telehealth platform. The 22,500-square-foot facility can process up to 5,000 daily prescriptions and is expected to be licensed across all 50 states, DC, and Puerto Rico by year-end. This integration is projected to generate $5 million in annualized expense savings. The pharmacy enhances LifeMD's vertically integrated platform, which includes proprietary virtual-care technology, a 50-state medical group, and a U.S.-based patient care center. The facility will enable personalized care packages and bundled shipments combining prescriptions and wellness products.
LifeMD (NASDAQ: LFMD) ha lanciato la sua farmacia affiliata all'avanguardia a Lancaster, PA, completando la sua piattaforma di telemedicina end-to-end. La struttura di 22.500 piedi quadrati può elaborare fino a 5.000 prescrizioni giornaliere ed è prevista per ottenere la licenza in tutti e 50 gli stati, nel DC e a Porto Rico entro la fine dell'anno. Questa integrazione si prevede che genererà 5 milioni di dollari di risparmi annualizzati sui costi. La farmacia migliora la piattaforma verticalmente integrata di LifeMD, che include tecnologia proprietaria di assistenza virtuale, un gruppo medico attivo in 50 stati e un centro di assistenza ai pazienti con sede negli Stati Uniti. La struttura consentirà pacchetti di assistenza personalizzati e spedizioni raggruppate che combinano prescrizioni e prodotti per il benessere.
LifeMD (NASDAQ: LFMD) ha lanzado su farmacia afiliada de última generación en Lancaster, PA, completando su plataforma de telemedicina integral. La instalación de 22,500 pies cuadrados puede procesar hasta 5,000 recetas diarias y se espera que obtenga licencia en todos los 50 estados, DC y Puerto Rico para fin de año. Se prevé que esta integración genere 5 millones de dólares en ahorros anuales en gastos. La farmacia mejora la plataforma verticalmente integrada de LifeMD, que incluye tecnología de atención virtual propia, un grupo médico en 50 estados y un centro de atención al paciente con sede en EE. UU. La instalación permitirá paquetes de atención personalizados y envíos combinados que incluyan recetas y productos de bienestar.
LifeMD (NASDAQ: LFMD)가 펜실베이니아주 랜카스터에 첨단 제휴 약국을 개설하며 엔드 투 엔드 원격 의료 플랫폼을 완성했습니다. 22,500제곱피트 규모의 시설은 하루 최대 5,000건의 처방전을 처리할 수 있으며, 연말까지 모든 50개 주와 워싱턴 D.C. 및 푸에르토리코에서 라이센스를 받을 것으로 예상됩니다. 이 통합은 연간 500만 달러의 비용 절감 효과를 가져올 것으로 예상됩니다. 이 약국은 LifeMD의 수직 통합 플랫폼을 강화하며, 여기에는 독점적인 가상 진료 기술, 50개 주에서 활동하는 의료 그룹, 미국에 기반을 둔 환자 치료 센터가 포함됩니다. 이 시설은 개인 맞춤형 치료 패키지와 처방전 및 웰니스 제품을 결합한 묶음 배송을 가능하게 합니다.
LifeMD (NASDAQ: LFMD) a lancé sa pharmacie affiliée à la pointe de la technologie à Lancaster, PA, complétant ainsi sa plateforme de télémédecine de bout en bout. L'établissement de 22 500 pieds carrés peut traiter jusqu'à 5 000 prescriptions par jour et devrait être autorisé dans les 50 États, à DC et à Porto Rico d'ici la fin de l'année. Cette intégration devrait générer 5 millions de dollars d'économies annuelles sur les dépenses. La pharmacie renforce la plateforme verticalement intégrée de LifeMD, qui comprend une technologie de soins virtuels propriétaire, un groupe médical dans 50 États et un centre de soins aux patients basé aux États-Unis. L'établissement permettra des forfaits de soins personnalisés et des expéditions regroupées combinant prescriptions et produits de bien-être.
LifeMD (NASDAQ: LFMD) hat seine hochmoderne angeschlossene Apotheke in Lancaster, PA, eröffnet und damit seine End-to-End-Telemedizinplattform vervollständigt. Die 22.500 Quadratfuß große Einrichtung kann bis zu 5.000 tägliche Verschreibungen bearbeiten und wird voraussichtlich bis zum Jahresende in allen 50 Bundesstaaten, DC und Puerto Rico lizenziert sein. Diese Integration wird voraussichtlich jährliche Einsparungen von 5 Millionen Dollar an Betriebskosten generieren. Die Apotheke verbessert die vertikal integrierte Plattform von LifeMD, zu der proprietäre virtuelle Versorgungstechnologie, eine medizinische Gruppe in 50 Bundesstaaten und ein Patientenversorgungszentrum mit Sitz in den USA gehören. Die Einrichtung ermöglicht personalisierte Pflegepakete und gebündelte Sendungen, die Verschreibungen und Gesundheitsprodukte kombinieren.
- New 22,500-square-foot pharmacy facility capable of processing 5,000 daily prescriptions
- Expected $5 million in annualized expense savings
- Expansion to all 50 states, DC, and Puerto Rico by year-end
- Vertical integration expected to improve operating margins
- None.
Insights
The launch of LifeMD's affiliated pharmacy represents a significant operational development with meaningful financial implications. The projected
The vertical integration strategy reduces third-party dependencies and associated costs while creating multiple revenue streams. The nationwide licensing approach (50 states, D.C. and Puerto Rico) maximizes the addressable market. This infrastructure investment positions LifeMD to capture higher margins across the entire patient care journey, from consultation to prescription fulfillment, potentially improving long-term profitability metrics and competitive positioning in the telehealth sector.
The establishment of an in-house pharmacy operation marks a strategic shift in LifeMD's business model, significantly enhancing operational control and efficiency. The vertical integration eliminates multiple handoffs in the prescription fulfillment process, reducing potential points of failure and improving patient satisfaction. The facility's location in Lancaster, PA, provides strategic geographic positioning for nationwide distribution.
The ability to offer bundled shipments and customized care packages creates differentiation in the competitive telehealth market. This end-to-end control over the patient journey enables better data collection, inventory management and quality control. The infrastructure investment in pharmacy capabilities is particularly timely given the growing demand for GLP-1 medications, positioning LifeMD to capture market share in this high-growth segment.
State-of-the-Art Pharmacy Completes LifeMD’s End-to-end Healthcare Platform, Supporting 5,000 Daily Orders, Improving Operating Margins, and Enabling Curated Care Journeys
NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the official opening of its state-of-the-art affiliated pharmacy, marking an important milestone in creating a fully integrated, end-to-end telehealth platform. This new 22,500-square-foot facility, located in Lancaster, PA and designed to fill up to 5,000 daily prescriptions, allows LifeMD to offer patients a more cohesive care journey for relevant conditions — from initial consultation to prescription fulfillment — within a single integrated ecosystem.
The launch of this pharmacy uniquely enhances LifeMD’s vertically integrated telehealth platform, which now includes a proprietary virtual-first care technology platform, a 50-state affiliated medical group, a U.S.-based patient care center, and a vertically integrated pharmacy. The integration of pharmacy services directly within the LifeMD platform is expected to yield substantial financial benefits, with LifeMD projecting approximately
Transformative Benefits of the New LifeMD Pharmacy:
- Complete, End-to-End Patient Experience: With the addition of pharmacy capabilities, LifeMD now offers a fully integrated and cohesive experience, ensuring continuity of care at every stage — from consultation and diagnosis to medication fulfillment — all managed within the LifeMD platform.
- Enhanced Capacity: With current capacity to process up to 5,000 daily prescriptions and the ability to expand, the pharmacy is poised to support LifeMD’s rapidly growing patient base, ensuring faster and more reliable medication delivery. This capacity will also enable the pharmacy to eventually support LifeMD’s expanding GLP-1 medication offerings.
- Cost Savings: By integrating pharmacy services, LifeMD projects annualized expense savings of approximately
$5 million . These savings enhance operating margins and enable further investments in patient care and platform enhancements. - Curated Patient Experience: The pharmacy allows LifeMD to deliver a personalized experience, including customized care packages and bundled shipments that combine prescription and wellness products, tailored to each patient’s unique needs and health journey.
"The launch of our affiliated pharmacy represents a transformative milestone for LifeMD as we become one of the few fully integrated telehealth providers in the country,” said Justin Schreiber, Chairman and CEO of LifeMD. “This facility will allow us to deliver a truly curated, end-to-end care experience that not only improves patient convenience and satisfaction, but also enhances the quality and affordability of care. With patients now offered a fully integrated journey, we are uniquely positioned to set a new standard in patient-centric telehealth and personalized healthcare.”
With its ecosystem, LifeMD is redefining virtual care through a holistic, vertically integrated model that combines purpose-built technology, a nationwide medical network, and a fully integrated pharmacy solution. This comprehensive infrastructure allows LifeMD to anticipate and meet the evolving needs of patients, offering unmatched convenience and continuity of care.
About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
FAQ
What is the capacity of LifeMD's new pharmacy facility in Lancaster, PA?
How much cost savings does LifeMD (LFMD) expect from its new pharmacy integration?
Where is LifeMD's (LFMD) new pharmacy facility located?
When will LifeMD's (LFMD) pharmacy be licensed across all states?
